Immune damage in Long Covid

Area of Science:

• Immunology and Hematology
• Pathophysiology of Infectious Diseases

Background:

• Long Covid, a complex post-viral syndrome, presents diverse and persistent symptoms.
• The complement system (part of innate immunity) and the coagulation system (blood clotting) are crucial for host defense and tissue repair.
• Dysregulation in these systems has been implicated in various inflammatory and thrombotic conditions.

Purpose of the Study:

• To explore the intricate crosstalk between the complement and coagulation cascades.
• To investigate the potential role of complement-coagulation interactions in the pathophysiology of Long Covid.
• To identify potential therapeutic targets within these interconnected systems for Long Covid treatment.

Main Methods:

• Review of existing literature on complement-coagulation interactions.
• Analysis of preclinical and clinical data linking immune and clotting pathways.
• Exploration of molecular mechanisms underlying complement activation and its effect on coagulation.

Main Results:

• Evidence suggests significant cross-activation between complement and coagulation pathways.
• Aberrant activation of these systems may contribute to the microvascular thrombosis and inflammation seen in Long Covid.
• Specific complement components and coagulation factors show potential as biomarkers and therapeutic targets.

Conclusions:

• The interplay between the complement and coagulation systems is a promising area for Long Covid research.
• Targeting this crosstalk could offer novel therapeutic avenues for managing Long Covid symptoms.
• Further investigation is warranted to translate these findings into clinical practice.